These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 38975728)
1. CD39 Is Expressed on Functional Effector and Tissue-resident Memory CD8+ T Cells. Isaacs JF; Degefu HN; Chen T; Kleist SA; Musial SC; Ford MA; Searles TG; Lin CC; Skorput AGJ; Shirai K; Turk MJ; Zanazzi GJ; Rosato PC J Immunol; 2024 Sep; 213(5):588-599. PubMed ID: 38975728 [TBL] [Abstract][Full Text] [Related]
2. CD39 is expressed on functional effector and tissue resident memory CD8+ T cells. Isaacs JF; Degefu HN; Chen T; Kleist SA; Musial SC; Ford MA; Searles TG; Lin CC; Skorput AGJ; Shirai K; Turk MJ; Zanazzi GJ; Rosato PC bioRxiv; 2024 Mar; ():. PubMed ID: 38559200 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory Molecules PD-1, CD73 and CD39 Are Expressed by CD8 Smith CJ; Snyder CM Front Immunol; 2021; 12():704862. PubMed ID: 34335618 [TBL] [Abstract][Full Text] [Related]
4. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity. Häusler SF; Montalbán del Barrio I; Strohschein J; Chandran PA; Engel JB; Hönig A; Ossadnik M; Horn E; Fischer B; Krockenberger M; Heuer S; Seida AA; Junker M; Kneitz H; Kloor D; Klotz KN; Dietl J; Wischhusen J Cancer Immunol Immunother; 2011 Oct; 60(10):1405-18. PubMed ID: 21638125 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity. Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716 [TBL] [Abstract][Full Text] [Related]
6. Regulatory role of CD39 and CD73 in tumor immunity. Kaplinsky N; Williams K; Watkins D; Adams M; Stanbery L; Nemunaitis J Future Oncol; 2024; 20(19):1367-1380. PubMed ID: 38652041 [TBL] [Abstract][Full Text] [Related]
7. CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8 Canale FP; Ramello MC; Núñez N; Araujo Furlan CL; Bossio SN; Gorosito Serrán M; Tosello Boari J; Del Castillo A; Ledesma M; Sedlik C; Piaggio E; Gruppi A; Acosta Rodríguez EA; Montes CL Cancer Res; 2018 Jan; 78(1):115-128. PubMed ID: 29066514 [TBL] [Abstract][Full Text] [Related]
9. CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma. Wang LL; Tang HP; Shi GC; Wan HY; Tang W; Hou XX; Pan LN; Shi BY; Tao LQ Mol Med Rep; 2013 Nov; 8(5):1432-8. PubMed ID: 24065069 [TBL] [Abstract][Full Text] [Related]
10. Deficient Resident Memory T Cell and CD8 T Cell Response to Commensals in Inflammatory Bowel Disease. Noble A; Durant L; Hoyles L; Mccartney AL; Man R; Segal J; Costello SP; Hendy P; Reddi D; Bouri S; Lim DNF; Pring T; O'Connor MJ; Datt P; Wilson A; Arebi N; Akbar A; Hart AL; Carding SR; Knight SC J Crohns Colitis; 2020 May; 14(4):525-537. PubMed ID: 31665283 [TBL] [Abstract][Full Text] [Related]
11. Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury. Bönner F; Borg N; Burghoff S; Schrader J PLoS One; 2012; 7(4):e34730. PubMed ID: 22514659 [TBL] [Abstract][Full Text] [Related]
12. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. Deaglio S; Dwyer KM; Gao W; Friedman D; Usheva A; Erat A; Chen JF; Enjyoji K; Linden J; Oukka M; Kuchroo VK; Strom TB; Robson SC J Exp Med; 2007 Jun; 204(6):1257-65. PubMed ID: 17502665 [TBL] [Abstract][Full Text] [Related]
13. CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia. Pulte D; Furman RR; Broekman MJ; Drosopoulos JH; Ballard HS; Olson KE; Kizer JR; Marcus AJ Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):367-72. PubMed ID: 21816376 [TBL] [Abstract][Full Text] [Related]
15. Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells. Martinez-Usatorre A; Carmona SJ; Godfroid C; Yacoub Maroun C; Labiano S; Romero P Front Immunol; 2020; 11():340. PubMed ID: 32174925 [TBL] [Abstract][Full Text] [Related]
16. Decreased Frequency of Intestinal CD39 Libera J; Wittner M; Kantowski M; Woost R; Eberhard JM; de Heer J; Reher D; Huber S; Haag F; Schulze Zur Wiesch J Front Immunol; 2020; 11():567472. PubMed ID: 33072107 [TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection. Jenabian MA; Seddiki N; Yatim A; Carriere M; Hulin A; Younas M; Ghadimi E; Kök A; Routy JP; Tremblay A; Sévigny J; Lelievre JD; Levy Y PLoS Pathog; 2013; 9(4):e1003319. PubMed ID: 23658513 [TBL] [Abstract][Full Text] [Related]
18. Intestinal tissue-resident memory T cells maintain distinct identity from circulating memory T cells after in vitro restimulation. Beumer-Chuwonpad A; Behr FM; van Alphen FPJ; Kragten NAM; Hoogendijk AJ; van den Biggelaar M; van Gisbergen KPJM Eur J Immunol; 2024 May; 54(5):e2350873. PubMed ID: 38501878 [TBL] [Abstract][Full Text] [Related]